- Investing Ideas
- /
- Diversified Financials Biotech Breakthroughs
Diversified Financials Biotech Breakthroughs
Results
29
0 new
Companys with strong funding and high growth potential
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
7M20 | US$8.22 | 5.1% | -15.0% | US$501.1m | US$8.14 | PB1.1x | E148.3% | 17.3% | ||
2AR | US$18.66 | -0.1% | -13.2% | US$1.0b | US$18.29 | PB0.9x | E156.4% | 13.8% | ||
6DR | AU$0.20 | -0.5% | -22.6% | AU$38.2m | n/a | PS1.1x | E114.8% | n/a | ||
71Y | US$23.68 | 7.1% | 33.8% | US$14.8b | US$24.38 | PS3.5x | E60.9% | n/a | ||
CHG | €23.60 | -3.3% | 74.8% | €547.2m | €27.76 | PS7.7x | E73.1% | n/a | ||
6HD | UK£1.89 | 1.1% | 137.7% | UK£386.8m | UK£2.13 | PS13.7x | E120.4% | n/a | ||
71Y | US$21.37 | 0% | 20.9% | US$15.2b | US$22.00 | PS3.5x | E60.9% | n/a | ||
45U0 | US$7.63 | 4.2% | -8.3% | US$620.8m | US$8.64 | PB1.1x | E114.4% | 17.2% | ||
900 | US$28.80 | 0% | 23.1% | US$4.1b | US$33.35 | PS11.6x | E107.9% | n/a | ||
6HT | CN¥0.44 | 0% | -20.7% | CN¥95.7b | n/a | PS8.1x | E81.2% | 1.1% | ||
CHG | €24.20 | 0% | 76.6% | €556.4m | €28.00 | PS7.9x | E73.1% | n/a | ||
4R6 | SEK 2.00 | -1.1% | -6.4% | SEK 4.7b | SEK 1.85 | PS2.6x | E71.5% | 0% | ||
B7E | €16.30 | -1.8% | -9.4% | €74.5m | €29.95 | PB0.9x | E61.3% | 3.9% | ||
LDD | US$2.46 | 7.0% | 46.4% | US$923.4m | US$2.10 | PB1.8x | E114.8% | 0% | ||
WF0 | UK£0.61 | 8.8% | -35.9% | UK£119.5m | UK£1.11 | PB0.5x | E19.7% | 0% | ||
SHK | HK$0.27 | 0% | -12.3% | HK$4.8b | n/a | PS2.4x | E70.6% | 10.6% | ||
52D0 | CA$0.089 | 3.2% | 5.6% | CA$103.8m | n/a | PS1.9x | E89.3% | n/a | ||
XTP | €53.00 | 1.0% | 86.0% | €123.9m | €75.85 | PS22.2x | E61.6% | 5.4% | ||
B7E | €16.60 | -1.2% | -7.8% | €74.5m | €30.50 | PB0.9x | E61.3% | 3.9% | ||
1IV | UK£8.52 | 1.1% | -10.2% | UK£4.0b | UK£9.77 | PB3.6x | E26.1% | 1.6% | ||
W4C | UK£1.45 | -5.8% | n/a | UK£157.8m | UK£1.50 | PS1.9x | E145.7% | 0% | ||
6B0 | US$7.30 | 7.4% | 2.2% | US$8.7b | US$7.92 | PS3.7x | E51.4% | n/a | ||
62E | CA$29.20 | -2.0% | n/a | CA$6.4b | CA$30.23 | PS3.6x | E96.7% | 1.2% | ||
6OI | US$15.20 | 0% | n/a | US$1.1b | US$20.30 | PS1.8x | E46.8% | n/a |